Yahoo Web Search

Search results

    • KRAS inhibitors: The next frontier beckons

      KRAS inhibitors: The next frontier beckons

      Pharmaceutical Technology via Yahoo Finance· 4 hours ago

      The trial met its primary endpoint, with 34% of the 94 metastatic colorectal cancer (CRC) patients reaching a median progression-free survival of 6.9...